Publications - 'D'

Publications 1501 - 1525 de 1753
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
Donor EBV status has impact on the incidence of acute and chronic GVHD
J. Styczynski; G. Tridello; L. Gil; P. Ljungman; J. Hoek; S. Iacobelli; C. Cordonnier; H. Einsele; K. Ward; G. Socie; N. Milpied; J.H. Veelken; P. Chevallier; I. Yakoub-Agha; J. Maertens; D. Blaise; J. Cornelissen; M. Michallet; E. Deconinck; E. Petersen; J. Passweg; H. Greinix; R. Duarte; N. Kroeger; P. Dreger; A. Nagler; S. Cesaro
2015
Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10
B. Lamarthee; F. Malard; C. Gamonet; C. Bossard; M. Couturier; J.C. Renauld; M. Mohty; P. Saas; B. Gaugler
2016
10.1038/mi.2015.61
Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
J. De Vos; E. Baudoux; J.O. Bay; B. Calmels; A. Cras; J.El Cheikh; M.A. Guerout-Verite; M.N. Lacassagne; S. Lamure; C. Letellier; A.L. Menard; E. Daguindau; X. Poire; I. Yakoub-Agha; T. Guillaume
2019
10.1016/j.bulcan.2018.10.002
Donor Lymphocyte Infusions After Haploidentical Stem Cell Transplantation with PTCy: A Study on Behalf of the CTIWP of the EBMT
N. Santoro; K. Mauff; R. Devillier; L. Castagna; Z. Gulbas; J. Diez-Martin; A. Bermudez; C.Herrera Arroyo; E. Deconinck; J. Sierra; M. Abecasis; H. Ozdogu; M.Caterina Mico; V. Rocha; D. Guyotat; Y. Chalandon; E. Forcade; H. Martin; R. Saccardi; S. Giebel; M. Di Ianni; J. Hoogenboom; L.C. de Wreede; A. Ruggeri; C. Chabannon
2020
Donor Lymphocyte Infusions After Haploidentical Stem Cell Transplantation with PTCy: A Study on Behalf of the CTIWP of the EBMT
N. Santoro; K. Mauff; R. Devillier; L. Castagna; Z. Gulbas; J. Diez-Martin; A. Bermudez; C.Herrera Arroyo; E. Deconinck; J. Sierra; M. Abecasis; H. Ozdogu; M.Caterina Mico; V. Rocha; D. Guyotat; Y. Chalandon; E. Forcade; H. Martin; R. Saccardi; S. Giebel; M. Di Ianni; J. Hoogenboom; L.C. de Wreede; A. Ruggeri; C. Chabannon
2020
Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT
A. Shimoni; M. Labopin; J. Finke; F. Ciceri; E. Deconinck; N. Kroger; M. Gramatzki; M. Stelljes; D. Blaise; F. Stoelzel; P. Chevallier; E. Holler; N. Fegueux; M. Mohty; A. Nagler
2019
10.1038/s41408-019-0251-3
Donor site morbidity after vascularized fibula free flap: gait analysis during prolonged walk conditions
N. Hadouiri; D. Feuvrier; J. Pauchot; P. Decavel; Y. Sagawa
2018
10.1016/j.ijom.2017.10.006
Donor sperm insemination after failed intra-couple intracytoplasmic sperm injection
S. Hennebicq; O. Blagosklonov; F. Eustache; A. Papaxanthos; V. Drouineaud; C. Guillemain; S. Mirallie; B. Delepine; N. Rives; I. Berthaut; C. Frapsauce; J.F. Guerin; M. Benchaib
2018
10.1080/19396368.2017.1382608
Donor-targeted serotherapy as a rescue therapy for steroid-resistant acute GVHD after HLA-mismatched kidney transplantation
J. Zuber; O. Boyer; B. Neven; I. Jollet; V. Renac; R. Berthaud; R. Levy; B. Lamarthee; J. Visentin; A. Marchal; N. Gouge-Biebuyck; A. Godron-Dubrasquet; N. Aladjidi; M.O. Rabah; S. Winter; J. Leon; M. Dussiot; M. Rabant; S. Krid; P. Krug; M. Charbit; F. Lacaille; I. Andre; M. Cavazzana; B. Llanas; L. Allard; F. Pirenne; S. Gross; R. Djoudi; P. Tiberghien; J.L. Taupin; S. Blanche; R. Salomon
2020
10.1111/ajt.15827
Donsker and Glivenko-Cantelli theorems for a class of processes generalizing the empirical process
D. Varron
2014
10.1214/14-EJS955
Doped Colloidal InAs Nanocrystals in the Single Ionized Dopant Limit
M. Biaye; Y. Amit; K. Gradkowski; N. Turek; S. Godey; Y. Makoudi; D. Deresmes; A. Tadjine; C. Delerue; U. Bailin; T. Melin
2019
10.1021/acs.jpcc.9b02576
Doppler effect as a tool for ultrashort electric field reconstruction
P. Bejot; E. Szmygel; A. Dubrouil; F. Billard; B. Lavorel; O. Faucher; E. Hertz
2020
10.1364/OL.402935
Doppler-free spectroscopy on the Cs D-1 line with a dual-frequency laser
M.Abdel Hafiz; G. Coget; E. de Clercq; R. Boudot
2016
10.1364/OL.41.002982
DORIS-class oscillator under radiations: the Jason family of satellites
A. Belli; P. Exertier; C. Jayles; F. Vernotte
2017
Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia
N. Azzopardi; S. Dupuis-Girod; D. Ternant; A.E. Fargeton; I. Ginon; F. Faure; E. Decullier; A. Roux; M.F. Carette; B. Gilbert-Dussardier; P.Y. Hatron; P. Lacombe; V. Leguy-Seguin; S. Riviere; R. Corre; S. Bailly; G. Paintaud
2015
10.1080/19420862.2015.1022693
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendations
J. Langrand-Escure; R. de Crevoisier; C. Llagostera; G. Crehange; G. Delaroche; C. Lafond; C. Bonin; F. Bideault; P. Sargos; S. Belhomme; D. Pasquier; I. Latorzeff; S. Supiot; C. Hennequin
2018
10.1016/j.canrad.2017.11.004
Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational study
L. Pouillon; A. Lamoureux; G.Pineton de Chambrun; L. Vuitton; B. Pariente; C. Zallot; G. Dufour; M. Fumery; C. Baumann; A. Amiot; S. Nancey; H. Rousseau; L. Peyrin-Biroulet
2019
10.1016/j.dld.2018.10.022
Dose of enteral nutrition and enterocyte biomarker: a circular link?
G. Piton; A. Le Gouge; J. Reignier
2019
10.1007/s00134-019-05697-9
Dose per muscle in cervical dystonia: pooled data from seven movement disorder centres
W.H. Jost; A. Druzdz; S. Pandey; B. Biering-Sorensen; A. Kreisler; L. Tatu; C.F. Altmann; J. Slawek
2021
10.5603/PJNNS.a2021.0005
Dose point kernels in liquid water: An intra-comparison between GEANT4-DNA and a variety of Monte Carlo codes
C. Champion; S. Incerti; Y. Perrot; R. Delorme; M.C. Bordage; M. Bardies; B. Mascialino; H.N. Tran; V. Ivanchenko; M. Bernal; Z. Francis; J.E. Groetz; M. Fromm; L. Campos
2014
10.1016/j.apradiso.2013.01.037
Dose-dependent biphasic leptin-induced proliferation is caused by non-specific IL-6/NF-B pathway activation in human myometrial cells
M. Barrichon; T. Hadi; M. Wendremaire; C. Ptasinski; R. Seigneuric; G. Marcion; M. Delignette; J. Marchet; M. Dumas; P. Sagot; M. Bardou; C. Garrido; F. Lirussi
2015
10.1111/bph.13100
Dose-effect response of elastic compression on muscular vibrations
T. Lussiana; A. Terrillon; J.L. Raynaud; N. Tordi; L. Mourot; A. Menetrier
2015
10.1016/j.scispo.2014.09.004
Dose-effect response of elastic compression on stride length
M. Pirard; J. Gellaerts; J. Muzic; M. Peseux; A. Menetrier
2016
10.1016/j.scispo.2016.07.006
Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT)
F. Blanc-Durand; C. Lefeuvre-Plesse; I. Ray-Coquard; D. Chaltiel; A. Floquet; E. Meriaux; D. Berton; D. Bello-Roufai; C. Guillemet; P.F. Dupre; E. Faller; J. Alexandre; A.C. Hardy-Bressard; O. Collard; M. Fabbro; M. Provansal; E. Kalbacher; C. Genestie; P. Pautier
2020
10.1016/j.ygyno.2020.07.019
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging
A. Laprie; S. Ken; T. Filleron; V. Lubrano; L. Vieillevigne; F. Tensaouti; I. Catalaa; S. Boetto; J. Khalifa; J. Attal; G. Peyraga; C. Gomez-Roca; E. Uro-Coste; G. Noel; G. Truc; M.P. Sunyach; N. Magne; M. Charissoux; S. Supiot; V. Bernier; M. Mounier; M. Poublanc; A. Fabre; J.P. Delord; E.CohenJona Moyal
2019
10.1186/s12885-019-5317-x

Pages